+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy Care

Pfizer

Overview

The Japanese Society for Cutaneous Immunology and Allergy (JSCIA) has entered into a collaboration agreement with Pfizer to address challenges in the clinical management of cutaneous immune-mediated, inflammation, and allergic diseases. This project aims to continuously improve the quality of healthcare by standardizing clinical practices and enhancing education in clinical settings. It invites and supports initiatives directed toward healthcare professionals. Through these efforts, the project seeks to strengthen expertise of healthcare professionals and promote a system that enables the provision of better care to patients.

Geographic Scope

Japan

Project Types and Area of Interest

Target diseases are cutaneous immune-mediated, inflammatory, and allergic diseases The purpose is to support the development of initiatives and frameworks that contribute to the continuous improvement of healthcare quality in the clinical management of cutaneous immune-mediated, inflammation, and allergy.

Funding Range and Project Length

Individual projects requesting up to 5M JPY will be considered. Total Amount approximately 10M JPY Project Duration : May 1, 2026 – April 30, 2029 (1 to 3 years)

AI based application success predictor

While Pfizer does not publish a universal scoring rubric, successful applications share several common features, based on how competitive RFPs are structured and how selections are typically made:

1) Strong Alignment With the RFP’s Topic + Unmet Need

Pfizer grant RFPs are narrow: they focus on a detailed research or clinical improvement question (e.g., pneumococcal carriage post-vaccine introduction).
➡️ Success predictor: Your proposal must directly address the specific gap and objectives articulated in the RFP.

2) Clear Relevance to Patient Outcomes or Public Health Impact

Pfizer emphasizes improving patient outcomes in areas of unmet medical need.
➡️ Success predictor: Demonstrate how your project will advance clinical understanding, improve care, or support better health outcomes rather than just adding incremental data.

3) Scientific Merit & Feasibility

Reviewers look for proposals that are:

Well-designed with appropriate methods.

Realistic timelines and achievable objectives.

Relevant preliminary data or rationale showing feasibility.
➡️ Success predictor: A compelling scientific plan that shows the project can be completed within the budget and time.

4) Organizational Capacity

Since grants are usually awarded to organizations (not individuals), institutions must demonstrate:

Ability to execute the project and manage funds.

Administrative and ethical oversight capacity (e.g., IRBs, data management).
➡️ Success predictor: Strong institutional backing and demonstrated project management ability.

5) Patient-Centered and Health Systems Relevance

Many grants (especially in clinical and QI spaces) look for work that will:

Inform clinical practice (e.g., therapy management).

Fill gaps in diagnosis, treatment adherence, or care delivery.
➡️ Success predictor: Projects that connect evidence generation to meaningful practice change or health care improvements are more competitive.

6) Budget Justification & Responsible Use of Funds

Grant proposals must include a realistic, justified budget tied to project activities.
➡️ Success predictor: Budgets that align precisely with what is needed to answer the RFP’s questions — without excess — are favored.

🧠 Practical Tips When Preparing a Pfizer Proposal

Here’s a quick checklist for competitive Pfizer grant applications:

✔ Extract the exact research or clinical gap the RFP describes.
✔ Frame your aims to directly respond to each RFP objective.
✔ Demonstrate measurable outcomes (e.g., clinical endpoints, educational improvements).
✔ Provide solid scientific or real-world evidence rationale.
✔ Show institutional capability and compliance readiness.
✔ Justify the budget tightly against deliverables.

📌 Summary

Pfizer’s research and independent grant portfolio isn’t a general investigator funding source — it’s RFP-driven and strategic, with success heavily reliant on:

Precision fit to the published topic.

Impact on health outcomes and unmet needs.

Scientific rigor and feasibility.

Organizational strength and execution plan.

Specialties

Allergy

Immunology

Eligibility Requirements

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement. Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society). Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions / organizations / associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project. The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator). The Project Lead/PI must be an employee or contractor of the requesting organization. Requesting organization must be legally able to receive award funding directly from Pfizer International LLC. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer International LLC may be subject to rescission.

Eligible Countries:

Japan

Sponsor Details

Sponsor Institute/Organizations: Pfizer

Sponsor Type: Corporate/Non-Profit

Address: 66 Hudson Boulevard East New York, NY 10001-2192

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity